The following statement can be attributed to Dr. Kyle Kingsley, Chief Executive Officer of Vireo Health International, Inc. (“Vireo” or “the Company”) (CNSX: VREO; OTCQX: VREOF), the leading science-focused, multi-state cannabis company:

“Much like the passage of its legislative predecessors, the 1937 Marijuana Tax Act and the 1970 Controlled Substances Act, today’s bipartisan approval of the 2019 SAFE Banking Act represents an historic milestone.

“Let’s hope that unlike earlier bills aimed at strengthening the prohibition of marijuana, the SAFE Banking Act will weaken it and pave the way for cannabis businesses, especially those owned by minority entrepreneurs, to gain full access to financial services.

“We thank all the Democratic and Republican representatives that voted to support this legislation and we hope that the U.S. Senate will pass this bill in a similar bipartisan manner.”

**Dr. Kingsley is available for interviews**

###

About Vireo Health International, Inc.

Vireo Health International, Inc.’s mission is to build the cannabis company of the future by bringing the best of medicine, engineering and science to the cannabis industry. Vireo’s physician-led team of nearly 400 employees provides best-in-class cannabis products and customer experience. Vireo cultivates cannabis in environmentally friendly greenhouses, manufactures pharmaceutical-grade cannabis extracts, and sells its products at both company-owned and third-party dispensaries. The Company currently is licensed in eleven markets including Arizona, Maryland, Massachusetts, Minnesota, New Mexico, New York, Ohio, Pennsylvania, Puerto Rico, and Rhode Island. For more information about the company, please visit www.vireohealth.com.





Contact Information



Media Inquiries

Albe Zakes

Vice President, Corporate Communications

albezakes@vireohealth.com

(267) 221-4800

Investor Inquiries

Sam Gibbons

Vice President, Investor Relations

samgibbons@vireohealth.com

(612) 314-8995